Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04840446 · ClinicalTrials.gov registry record

Evaluation of Modified Adhesives With Dexcom G6 Sensor

A clinical trial of Diabetes, sponsored by DexCom.

Completed
Registry status
80
Enrollment target
1
Study location

NCT04840446: Completed study of Diabetes, sponsored by DexCom.

NCT04840446 is a study of Diabetes that has completed, run by DexCom. The registered enrollment target is 80 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04840446, a study of Diabetes, has completed, sponsored by DexCom.

COMPLETED
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to collect and compare information on the performance of CGM adhesives in adults.

Primary Outcome

Number of adhesives that survive on the body during wear period

Conditions Studied

Interventions

  • DEVICE Dexcom Continuous Glucose Monitoring System

Study Locations (1)

Florida

  • Jaeb Center for Health Research - Tampa

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2021-02-08
Est. Completion 2021-03-19
DexCom

26 total trials

What the finished NCT04840446 record still lists

NCT04840446 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Dexcom Continuous Glucose Monitoring System is the first listed.

NCT04840446 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT04840446 about?

NCT04840446 is a clinical study titled "Evaluation of Modified Adhesives With Dexcom G6 Sensor". The purpose of the study is to collect and compare information on the performance of CGM adhesives in adults.

What is the current status of trial NCT04840446?

This trial is currently completed. The enrollment target is 80 participants. The study started on 2021-02-08. Estimated completion is 2021-03-19.

What conditions does trial NCT04840446 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT04840446?

The interventions under investigation include: Dexcom Continuous Glucose Monitoring System (DEVICE).

Who is sponsoring clinical trial NCT04840446?

This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04840446 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04840446's enrollment target sits among peer trials

80 212th of 338 higher than 124 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04840446, the US trial registry maintained by the National Library of Medicine. NCT04840446 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.